At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Low Doses of Ketamine on Postoperative Quality of Recovery After Total Intravenous Anesthesia
In Brief
A Phase 4 clinical trial evaluating Ketamine 0.4 mg/kg, Normal saline, and 1 other intervention for Postoperative Pain and Postoperative Nausea and Vomiting. Completed, enrolled 135 participants across 1 site.
Detailed Summary
There are evidences that intraoperative administration of low doses of ketamine may contribute to control the postoperative pain by acting on the N-methyl-D-aspartate (NMDA) channel, reducing the effects related to the tolerance and hyperalgesia induced by opioids. This study aims to evaluate the effects of administration of this agent not only as an analgesic but also its role in the quality of recovery from anesthesia, which includes observation of emotional, psychological and physical aspects. Patients who were scheduled to undergo total intravenous anesthesia (TIVA) for laparoscopic cholecystectomy will be enrolled in this clinical study. After induction of anesthesia, patients will receive one of three solutions according to the randomly selected group: ketamine 0,2 mg/kg; ketamine 0,4 mg/kg or saline. In the recovery room and on the ward, data related to the presence of pain, analgesic consumption, the incidence of nausea and vomiting, dizziness or hallucinations will be recorded. The next day, the quality of recovery will be evaluated by application of the questionnaire QoR40 (Quality of Recovery Questionnaire-40).
Study Details
Timeline
Interventions
Intravenous ketamine 0.4 mg/kg after induction of anesthesia
Intravenous normal saline 0.9% 5 mL
Intravenous ketamine 0.2 mg/kg after induction of anesthesia